ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Rituxan hits endpoints in late-stage skin disease trial pharmatimes
June 16, 2019Roche has announced that its monoclonal antibody, Rituxan (rituximab), met all primary and secondary endpoints in the Phase III PEMPHIX study. -
Zerbaxa Meets Primary Endpoints
americanpharmaceuticalreview
September 12, 2018Merck announced the pivotal Phase 3 clinical study evaluating the company’s antibiotic Zerbaxa (ceftolozane and tazobactam) at an investigational dose for the treatment of adult patients with either ventilated hospital-acquired bacterial pneumonia (HABP) -
Ionis Announces Phase 3 NEURO-TTR Study of Inotersen Meets Primary Endpoints
americanpharmaceuticalreview
May 16, 2017Ionis Pharmaceuticals announced the Phase 3 NEURO-TTR study of inotersen (IONIS-TTRRx) in patients with familial amyloid polyneuropathy (FAP) met both primary endpoints.
Pharma Sources Insight January 2025
